HB 127Alabama

Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

In committee

Jan 13, 2026: Read for the first time and referred to the House Committee on Health

Follow this bill Ratifi